Founded in 2016, Help Therapeutics is a globally clinical-stage biopharmaceutical company dedicated to the development of first-in-class iPSC-derived cell therapeutics for patients with degenerative diseases. Help Therapeutics is committed to driving and empowering off-the-shelf cell therapy products in the fields of cardiac failure, neurodegenerative diseases, and oncology. At Help Therapeutics, we believe that the best way to deliver safe, effective and revolutionary cell therapy products is to provide superior development and manufacturing technologies, value and support at every stage of the journey to bring the next generation advanced therapies to patients in deed. To learn more, visit en.helptherapeutics.com.

The Chinese American Biopharmaceutical Society (CABS) is a non-profit organization for professionals in the life sciences industry, headquartered in San Francisco, California. We are currently serving over 3000 members and subscribers in the life sciences community in US, China and Pacific Rim countries. We organize year-round programs including scientific workshops, business forums, mentorship program, social and networking events.CABS is the organizer of the BioPacific Conference, a highly anticipated annual life sciences event attended by hundreds of industry experts, employers, entrepreneurs, venture capitalists, academics and professionals.

Enverest enables Chinese and APAC enterprises and startups to engage industry experts and advisors to innovate and globalize. Headquartered in Silicon Valley, Enverest has branches in China and Singapore. We specialize in life sciences, energy & materials, frontier tech, among other industrial fields.Enverest leverages our trans-pacific business expertise and network to help Chinese/APAC clients in cross-border investment and M&A. We provide professional, full-stack advisory services throughout the investment process, starting from identifying investment opportunities, to due diligence, to transaction execution and beyond.

• Graduated from Thermo Fisher Graduate Leadership Development Program• Initiated and developed business case that led to acquisition of picoSpin, LLC in 2012• Conducted business development due diligence in partnership and M&A deals in Specialty Diagnostics Group• Developed product strategies to focus on high gain accounts in hospitals and reference labs for US cancer diagnostics markets; accomplished 5% incremental revenue growth in the first year• Developed and implemented portfolio management framework for over 200 product development projects in the $1.5 B Specialty Diagnostics Group• Launched two new products in a highly competitive cancer diagnostics market

• Created a road map for investment opportunities of Cornell University technologies• Pursued business development initiatives for a biotech startup in Lux Capital portfolio

• Directed drug discovery collaborations in cancer and diabetes therapeutic areas• Planned and managed outsourcing projects with contract research (CRO) partners in China• Built infrastructure in industry-best combinatorial and parallel synthesis laboratory